Slide of the Month
“Metro Map” analysis of FDA facilitated regulatory pathways and their influence on median approval times.
CONTACT US
MEMBER LOGIN
WHERE TO MEET US
Attendance at upcoming meetings and conferences
- PharmaVision 2017: Reinvigorating Indian pharma with incremental innovation, better regulatory compliance and enhanced global reach; 6 September 2017, Hyderabad, India; 8 September 2017, Mumbai, India
- ANVISA Knowledge Week; 20-21 September 2017 Brasilia, Brazil
- Copenhagen Centre for Regulatory Science (CORS): Transparency in regulatory decision making – opinions, examples and perspectives; 2 October 2017, Copenhagen, Denmark
- TOPRA Annual Symposium 2017: Collaboration, strategies, solutions; Global regulatory approaches to improve healthcare; 3-6 October 2017, London, UK
- Sindusfarma: Risk-based approaches to accelerating regulatory submissions and approvals; 17 October 2017, Sao Paulo, Brazil
READ
Our most recent publications
R&D Briefing 62: New drug approvals in ICH countries 2007 – 2016
R&D Briefing 61: Building quality into decision-making processes in medicines’ development, regulatory review and health technology assessment
View more